Index
1 Market Overview
1.1 Product Overview and Scope of Medical Radioisotopes
1.2 Classification of Medical Radioisotopes by Type
1.2.1 Overview: Global Medical Radioisotopes Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Medical Radioisotopes Revenue Market Share by Type in 2021
1.2.3 Tc-99m
1.2.4 Cobalt-60
1.2.5 Iodine Radioisotopes
1.3 Global Medical Radioisotopes Market by Application
1.3.1 Overview: Global Medical Radioisotopes Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Global Medical Radioisotopes Market Size & Forecast
1.5 Global Medical Radioisotopes Market Size and Forecast by Region
1.5.1 Global Medical Radioisotopes Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Medical Radioisotopes Market Size by Region, (2017-2022)
1.5.3 North America Medical Radioisotopes Market Size and Prospect (2017-2028)
1.5.4 Europe Medical Radioisotopes Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Medical Radioisotopes Market Size and Prospect (2017-2028)
1.5.6 South America Medical Radioisotopes Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Medical Radioisotopes Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Medical Radioisotopes Market Drivers
1.6.2 Medical Radioisotopes Market Restraints
1.6.3 Medical Radioisotopes Trends Analysis
2 Company Profiles
2.1 NRG
2.1.1 NRG Details
2.1.2 NRG Major Business
2.1.3 NRG Medical Radioisotopes Product and Solutions
2.1.4 NRG Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 NRG Recent Developments and Future Plans
2.2 IRE
2.2.1 IRE Details
2.2.2 IRE Major Business
2.2.3 IRE Medical Radioisotopes Product and Solutions
2.2.4 IRE Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 IRE Recent Developments and Future Plans
2.3 ANSTO
2.3.1 ANSTO Details
2.3.2 ANSTO Major Business
2.3.3 ANSTO Medical Radioisotopes Product and Solutions
2.3.4 ANSTO Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 ANSTO Recent Developments and Future Plans
2.4 NTP Radioisotopes
2.4.1 NTP Radioisotopes Details
2.4.2 NTP Radioisotopes Major Business
2.4.3 NTP Radioisotopes Medical Radioisotopes Product and Solutions
2.4.4 NTP Radioisotopes Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 NTP Radioisotopes Recent Developments and Future Plans
2.5 China National Nuclear Corporation
2.5.1 China National Nuclear Corporation Details
2.5.2 China National Nuclear Corporation Major Business
2.5.3 China National Nuclear Corporation Medical Radioisotopes Product and Solutions
2.5.4 China National Nuclear Corporation Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 China National Nuclear Corporation Recent Developments and Future Plans
2.6 Rosatom
2.6.1 Rosatom Details
2.6.2 Rosatom Major Business
2.6.3 Rosatom Medical Radioisotopes Product and Solutions
2.6.4 Rosatom Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Rosatom Recent Developments and Future Plans
2.7 Nordion
2.7.1 Nordion Details
2.7.2 Nordion Major Business
2.7.3 Nordion Medical Radioisotopes Product and Solutions
2.7.4 Nordion Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Nordion Recent Developments and Future Plans
2.8 Eckert & Ziegler Strahlen
2.8.1 Eckert & Ziegler Strahlen Details
2.8.2 Eckert & Ziegler Strahlen Major Business
2.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Product and Solutions
2.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Eckert & Ziegler Strahlen Recent Developments and Future Plans
2.9 Polatom
2.9.1 Polatom Details
2.9.2 Polatom Major Business
2.9.3 Polatom Medical Radioisotopes Product and Solutions
2.9.4 Polatom Medical Radioisotopes Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Polatom Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Medical Radioisotopes Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Medical Radioisotopes Players Market Share in 2021
3.2.2 Top 10 Medical Radioisotopes Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Medical Radioisotopes Players Head Office, Products and Services Provided
3.4 Medical Radioisotopes Mergers & Acquisitions
3.5 Medical Radioisotopes New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Medical Radioisotopes Revenue and Market Share by Type (2017-2022)
4.2 Global Medical Radioisotopes Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Medical Radioisotopes Revenue Market Share by Application (2017-2022)
5.2 Global Medical Radioisotopes Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Medical Radioisotopes Revenue by Type (2017-2028)
6.2 North America Medical Radioisotopes Revenue by Application (2017-2028)
6.3 North America Medical Radioisotopes Market Size by Country
6.3.1 North America Medical Radioisotopes Revenue by Country (2017-2028)
6.3.2 United States Medical Radioisotopes Market Size and Forecast (2017-2028)
6.3.3 Canada Medical Radioisotopes Market Size and Forecast (2017-2028)
6.3.4 Mexico Medical Radioisotopes Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Medical Radioisotopes Revenue by Type (2017-2028)
7.2 Europe Medical Radioisotopes Revenue by Application (2017-2028)
7.3 Europe Medical Radioisotopes Market Size by Country
7.3.1 Europe Medical Radioisotopes Revenue by Country (2017-2028)
7.3.2 Germany Medical Radioisotopes Market Size and Forecast (2017-2028)
7.3.3 France Medical Radioisotopes Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Medical Radioisotopes Market Size and Forecast (2017-2028)
7.3.5 Russia Medical Radioisotopes Market Size and Forecast (2017-2028)
7.3.6 Italy Medical Radioisotopes Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Medical Radioisotopes Revenue by Type (2017-2028)
8.2 Asia-Pacific Medical Radioisotopes Revenue by Application (2017-2028)
8.3 Asia-Pacific Medical Radioisotopes Market Size by Region
8.3.1 Asia-Pacific Medical Radioisotopes Revenue by Region (2017-2028)
8.3.2 China Medical Radioisotopes Market Size and Forecast (2017-2028)
8.3.3 Japan Medical Radioisotopes Market Size and Forecast (2017-2028)
8.3.4 South Korea Medical Radioisotopes Market Size and Forecast (2017-2028)
8.3.5 India Medical Radioisotopes Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Medical Radioisotopes Market Size and Forecast (2017-2028)
8.3.7 Australia Medical Radioisotopes Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Medical Radioisotopes Revenue by Type (2017-2028)
9.2 South America Medical Radioisotopes Revenue by Application (2017-2028)
9.3 South America Medical Radioisotopes Market Size by Country
9.3.1 South America Medical Radioisotopes Revenue by Country (2017-2028)
9.3.2 Brazil Medical Radioisotopes Market Size and Forecast (2017-2028)
9.3.3 Argentina Medical Radioisotopes Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Medical Radioisotopes Revenue by Type (2017-2028)
10.2 Middle East & Africa Medical Radioisotopes Revenue by Application (2017-2028)
10.3 Middle East & Africa Medical Radioisotopes Market Size by Country
10.3.1 Middle East & Africa Medical Radioisotopes Revenue by Country (2017-2028)
10.3.2 Turkey Medical Radioisotopes Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Medical Radioisotopes Market Size and Forecast (2017-2028)
10.3.4 UAE Medical Radioisotopes Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Medical Radioisotopes Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Medical Radioisotopes Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Medical Radioisotopes Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Medical Radioisotopes Revenue (USD Million) by Region (2017-2022)
Table 5. Global Medical Radioisotopes Revenue Market Share by Region (2023-2028)
Table 6. NRG Corporate Information, Head Office, and Major Competitors
Table 7. NRG Major Business
Table 8. NRG Medical Radioisotopes Product and Solutions
Table 9. NRG Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. IRE Corporate Information, Head Office, and Major Competitors
Table 11. IRE Major Business
Table 12. IRE Medical Radioisotopes Product and Solutions
Table 13. IRE Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. ANSTO Corporate Information, Head Office, and Major Competitors
Table 15. ANSTO Major Business
Table 16. ANSTO Medical Radioisotopes Product and Solutions
Table 17. ANSTO Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. NTP Radioisotopes Corporate Information, Head Office, and Major Competitors
Table 19. NTP Radioisotopes Major Business
Table 20. NTP Radioisotopes Medical Radioisotopes Product and Solutions
Table 21. NTP Radioisotopes Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. China National Nuclear Corporation Corporate Information, Head Office, and Major Competitors
Table 23. China National Nuclear Corporation Major Business
Table 24. China National Nuclear Corporation Medical Radioisotopes Product and Solutions
Table 25. China National Nuclear Corporation Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Rosatom Corporate Information, Head Office, and Major Competitors
Table 27. Rosatom Major Business
Table 28. Rosatom Medical Radioisotopes Product and Solutions
Table 29. Rosatom Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Nordion Corporate Information, Head Office, and Major Competitors
Table 31. Nordion Major Business
Table 32. Nordion Medical Radioisotopes Product and Solutions
Table 33. Nordion Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Eckert & Ziegler Strahlen Corporate Information, Head Office, and Major Competitors
Table 35. Eckert & Ziegler Strahlen Major Business
Table 36. Eckert & Ziegler Strahlen Medical Radioisotopes Product and Solutions
Table 37. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Polatom Corporate Information, Head Office, and Major Competitors
Table 39. Polatom Major Business
Table 40. Polatom Medical Radioisotopes Product and Solutions
Table 41. Polatom Medical Radioisotopes Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Medical Radioisotopes Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Medical Radioisotopes Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Medical Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Medical Radioisotopes Players Head Office, Products and Services Provided
Table 46. Medical Radioisotopes Mergers & Acquisitions in the Past Five Years
Table 47. Medical Radioisotopes New Entrants and Expansion Plans
Table 48. Global Medical Radioisotopes Revenue (USD Million) by Type (2017-2022)
Table 49. Global Medical Radioisotopes Revenue Share by Type (2017-2022)
Table 50. Global Medical Radioisotopes Revenue Forecast by Type (2023-2028)
Table 51. Global Medical Radioisotopes Revenue by Application (2017-2022)
Table 52. Global Medical Radioisotopes Revenue Forecast by Application (2023-2028)
Table 53. North America Medical Radioisotopes Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Medical Radioisotopes Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Medical Radioisotopes Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Medical Radioisotopes Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Medical Radioisotopes Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Medical Radioisotopes Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Medical Radioisotopes Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Medical Radioisotopes Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Medical Radioisotopes Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Medical Radioisotopes Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Medical Radioisotopes Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Medical Radioisotopes Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Medical Radioisotopes Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Medical Radioisotopes Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Medical Radioisotopes Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Medical Radioisotopes Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Medical Radioisotopes Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Medical Radioisotopes Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Medical Radioisotopes Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Medical Radioisotopes Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Medical Radioisotopes Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Medical Radioisotopes Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Medical Radioisotopes Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Medical Radioisotopes Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Medical Radioisotopes Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Medical Radioisotopes Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Medical Radioisotopes Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Medical Radioisotopes Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Medical Radioisotopes Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Medical Radioisotopes Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Medical Radioisotopes Picture
Figure 2. Global Medical Radioisotopes Revenue Market Share by Type in 2021
Figure 3. Tc-99m
Figure 4. Cobalt-60
Figure 5. Iodine Radioisotopes
Figure 6. Medical Radioisotopes Revenue Market Share by Application in 2021
Figure 7. Nuclear Therapy Picture
Figure 8. Equipment Radioactive Source Picture
Figure 9. Diagnosis Picture
Figure 10. Others Picture
Figure 11. Global Medical Radioisotopes Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Medical Radioisotopes Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Medical Radioisotopes Revenue Market Share by Region (2017-2028)
Figure 14. Global Medical Radioisotopes Revenue Market Share by Region in 2021
Figure 15. North America Medical Radioisotopes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Medical Radioisotopes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Medical Radioisotopes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Medical Radioisotopes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Medical Radioisotopes Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Medical Radioisotopes Market Drivers
Figure 21. Medical Radioisotopes Market Restraints
Figure 22. Medical Radioisotopes Market Trends
Figure 23. NRG Recent Developments and Future Plans
Figure 24. IRE Recent Developments and Future Plans
Figure 25. ANSTO Recent Developments and Future Plans
Figure 26. NTP Radioisotopes Recent Developments and Future Plans
Figure 27. China National Nuclear Corporation Recent Developments and Future Plans
Figure 28. Rosatom Recent Developments and Future Plans
Figure 29. Nordion Recent Developments and Future Plans
Figure 30. Eckert & Ziegler Strahlen Recent Developments and Future Plans
Figure 31. Polatom Recent Developments and Future Plans
Figure 32. Global Medical Radioisotopes Revenue Share by Players in 2021
Figure 33. Medical Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Medical Radioisotopes Revenue Market Share in 2021
Figure 35. Global Top 10 Players Medical Radioisotopes Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Medical Radioisotopes Revenue Share by Type in 2021
Figure 38. Global Medical Radioisotopes Market Share Forecast by Type (2023-2028)
Figure 39. Global Medical Radioisotopes Revenue Share by Application in 2021
Figure 40. Global Medical Radioisotopes Market Share Forecast by Application (2023-2028)
Figure 41. North America Medical Radioisotopes Sales Market Share by Type (2017-2028)
Figure 42. North America Medical Radioisotopes Sales Market Share by Application (2017-2028)
Figure 43. North America Medical Radioisotopes Revenue Market Share by Country (2017-2028)
Figure 44. United States Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Medical Radioisotopes Sales Market Share by Type (2017-2028)
Figure 48. Europe Medical Radioisotopes Sales Market Share by Application (2017-2028)
Figure 49. Europe Medical Radioisotopes Revenue Market Share by Country (2017-2028)
Figure 50. Germany Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Medical Radioisotopes Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Medical Radioisotopes Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Medical Radioisotopes Revenue Market Share by Region (2017-2028)
Figure 58. China Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Medical Radioisotopes Sales Market Share by Type (2017-2028)
Figure 65. South America Medical Radioisotopes Sales Market Share by Application (2017-2028)
Figure 66. South America Medical Radioisotopes Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Medical Radioisotopes Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Medical Radioisotopes Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Medical Radioisotopes Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Medical Radioisotopes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source